LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 9 of total 9

Search options

  1. Article ; Online: The 90% effective concentration of alfentanil combined with 0.075% ropivacaine for epidural labor analgesia: a single-center, prospective, double-blind sequential allocation biased-coin design.

    Jia, Chang / Zou, Bin / Sun, Ying-Jie / Han, Bo / Diao, Yu-Gang / Li, Ya-Ting / Cao, Hui-Juan

    Journal of anesthesia

    2024  Volume 38, Issue 3, Page(s) 377–385

    Abstract: Purpose: More literature studies have reported that alfentanil is safe and effective for labor analgesia. However, there is no unified consensus on the optimal dosage of alfentanil used for epidural analgesia. This study explored the concentration at 90% ...

    Abstract Purpose: More literature studies have reported that alfentanil is safe and effective for labor analgesia. However, there is no unified consensus on the optimal dosage of alfentanil used for epidural analgesia. This study explored the concentration at 90% of minimum effective concentration (EC90) of alfentanil combined with 0.075% ropivacaine in patients undergoing epidural labor analgesia to infer reasonable drug compatibility and provide guidance for clinical practice.
    Methods: In this prospective, single-center, double-blind study, a total of 45 singleton term primiparas with vaginal delivery who volunteered for epidural labor analgesia were recruited. The first maternal was administered with 3 μg/mL alfentanil combined with 0.075% ropivacaine with the infusion of 10 mL of the mixture every 50 min at a background dose of 3 mL/h. In the absence of PCEA, a total of 15 mL of the mixture is injected per hour. The subsequent alfentanil concentration was determined on the block efficacy of the previous case, using an up-down sequential allocation with a bias-coin design. 30 min after epidural labor analgesia, the block of patient failed with visual analog score (VAS) > 3, the alfentanil concentration was increased in a 0.5 μg/mL gradient for the next patient, while the block was successful with VAS ≤ 3, the alfentanil concentration was remained or decreased in a gradient according to a randomized response list for the next patient. EC90 and 95% confidence interval were calculated by linear interpolation and prediction model with R statistical software.
    Results: In this study, the estimated EC90 of alfentanil was 3.85 μg/mL (95% confidence interval, 3.64-4.28 μg/mL).
    Conclusion: When combined with ropivacaine 0.075%, the EC90 of alfentanil for epidural labor analgesia is 3.85 μg/mL in patients undergoing labor analgesia.
    MeSH term(s) Humans ; Ropivacaine/administration & dosage ; Female ; Double-Blind Method ; Alfentanil/administration & dosage ; Pregnancy ; Analgesia, Epidural/methods ; Prospective Studies ; Adult ; Anesthetics, Local/administration & dosage ; Analgesia, Obstetrical/methods ; Analgesics, Opioid/administration & dosage ; Dose-Response Relationship, Drug ; Pain Measurement/methods ; Pain Measurement/drug effects
    Language English
    Publishing date 2024-03-05
    Publishing country Japan
    Document type Journal Article ; Randomized Controlled Trial
    ZDB-ID 1107821-2
    ISSN 1438-8359 ; 0913-8668
    ISSN (online) 1438-8359
    ISSN 0913-8668
    DOI 10.1007/s00540-024-03322-8
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: [Effect of transcutaneous electrical acupoint stimulation on catheter related bladder discomfort after ureteroscopic lithotripsy].

    Gao, Peng / Shao, Bing / Diao, Yu-Gang / Zhang, Tie-Zheng / Li, Lin

    Zhongguo zhen jiu = Chinese acupuncture & moxibustion

    2020  Volume 40, Issue 8, Page(s) 829–833

    Abstract: Objective: To verify the efficacy of transcutaneous electrical acupoint stimulation (TEAS) on catheter related bladder discomfort after ureteroscopic lithotripsy.: Methods: Sixty male patients with selective ureteroscopic lithotripsy under general ... ...

    Abstract Objective: To verify the efficacy of transcutaneous electrical acupoint stimulation (TEAS) on catheter related bladder discomfort after ureteroscopic lithotripsy.
    Methods: Sixty male patients with selective ureteroscopic lithotripsy under general anesthesia were randomly divided into a TEAS group (30 cases, one case dropped off) and a sham TEAS group (30 cases, 2 cases dropped off). Before anesthesia induction, the patients in the TEAS group were treated with TEAS at Guanyuan (CV 4), Zhongji (CV 3), Zusanli (ST 36) and Sanyinjiao (SP 6) for 30 min, with disperse-dense wave, frequency of 2 Hz/ 15 Hz and current intensity of 6 to 10 mA. The patients in the sham TEAS group were treated with the same TEAS device at the same acupoints, but no electrical stimulation was given. After 30 min, anesthesia induction started. The total dosages of propofol and remifentanil in the two groups were recorded, and the time of operation and anesthesia, the time of wake-up and the time of stay in postanesthesia care unit (PACU) were recorded. The postoperative recovery was evaluated 5 min (T
    Results: The dosage of remifentanil in the TEAS group was significantly lower than that in the sham TEAS group (
    Conclusion: The 30-min TEAS at Guanyuan (CV 4), Zhongji (CV 3), Zusanli (ST 36) and Sanyinjiao (SP 6) before anesthesia induction could significantly control the severity of postoperative urinary tract irritation in patients with ureteroscopic lithotripsy, reduce the dosage of anesthetic drugs and relieve postoperative pain.
    MeSH term(s) Acupuncture Points ; Humans ; Lithotripsy/adverse effects ; Male ; Pain Management/methods ; Transcutaneous Electric Nerve Stimulation ; Ureteroscopy/adverse effects ; Urinary Bladder
    Language Chinese
    Publishing date 2020-09-01
    Publishing country China
    Document type Journal Article ; Randomized Controlled Trial
    ISSN 0255-2930
    ISSN 0255-2930
    DOI 10.13703/j.0255-2930.20190729-k0001
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: A role of GABA

    Tang, Xiao-Hui / Diao, Yu-Gang / Ren, Zhuo-Yu / Zang, Yan-Yu / Zhang, Guang-Fen / Wang, Xing-Ming / Duan, Gui-Fang / Shen, Jin-Chun / Hashimoto, Kenji / Zhou, Zhi-Qiang / Yang, Jian-Jun

    Neuropharmacology

    2022  Volume 225, Page(s) 109383

    Abstract: Ketamine can produce rapid-acting antidepressant effects in treatment-resistant patients with depression. Although alterations in glutamatergic and GABAergic neurotransmission in the brain play a role in depression, the precise molecular mechanisms in ... ...

    Abstract Ketamine can produce rapid-acting antidepressant effects in treatment-resistant patients with depression. Although alterations in glutamatergic and GABAergic neurotransmission in the brain play a role in depression, the precise molecular mechanisms in these neurotransmission underlying ketamine's antidepressant actions remain largely unknown. Mice exposed to FSS (forced swimming stress) showed depression-like behavior and decreased levels of GABA (γ-aminobutyric acid), but not glutamate, in the hippocampus. Ketamine increased GABA levels and decreased glutamate levels in the hippocampus of mice exposed to FSS. There was a correlation between GABA levels and depression-like behavior. Furthermore, ketamine increased the levels of enzymes and transporters on the GABAergic neurons (SAT1, GAD67, GAD65, VGAT and GAT1) and astrocytes (EAAT2 and GAT3), without affecting the levels of enzymes and transporters (SAT2, VGluT1 and GABA
    MeSH term(s) Mice ; Animals ; Receptors, GABA-A/metabolism ; Ketamine/therapeutic use ; Antidepressive Agents/pharmacology ; Antidepressive Agents/metabolism ; Hippocampus/metabolism ; GABA Antagonists ; GABAergic Neurons/metabolism ; gamma-Aminobutyric Acid/metabolism ; Depression/drug therapy
    Chemical Substances Receptors, GABA-A ; Ketamine (690G0D6V8H) ; Antidepressive Agents ; GABA Antagonists ; gamma-Aminobutyric Acid (56-12-2)
    Language English
    Publishing date 2022-12-21
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 218272-5
    ISSN 1873-7064 ; 0028-3908
    ISSN (online) 1873-7064
    ISSN 0028-3908
    DOI 10.1016/j.neuropharm.2022.109383
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Perioperative intravenous S(+)-ketamine for acute postoperative pain in adults: study protocol for a multicentre, randomised, open-label, positive-controlled, pragmatic clinical trial (SAFE-SK-A trial).

    Wang, Hong / Duan, Chong-Yang / Huang, Wen-Qi / Zhao, Ping / Zhou, Li-Zhi / Liu, Yan-Hong / Liu, Cun-Ming / Chu, Hai-Chen / Wang, Qiang / Diao, Yu-Gang / Hua, Zhen / Meng, Qing-Tao / Li, Hao / Zhang, Xiao-Ying / Mi, Wei-Dong / Chen, Ping-Yan

    BMJ open

    2021  Volume 11, Issue 12, Page(s) e054681

    Abstract: Introduction: Postoperative pain remains incompletely controlled for decades. Recently, multimodal analgesia is emerging as a potential approach in the management of postoperative pain. Therein, S(+)-ketamine is appealing as an adjuvant drug in ... ...

    Abstract Introduction: Postoperative pain remains incompletely controlled for decades. Recently, multimodal analgesia is emerging as a potential approach in the management of postoperative pain. Therein, S(+)-ketamine is appealing as an adjuvant drug in multimodal analgesia due to its unique pharmacological advantages. This pragmatic clinical trial (SAFE-SK-A trial) is designed to investigate the analgesic effect and safety of S(+)-ketamine for acute postoperative pain in adults and explore the optimal strategy of perioperative intravenous S(+)-ketamine in a real-world setting.
    Methods and analysis: This multicentre, randomised, open-label, positive-controlled, pragmatic clinical trial (SAFE-SK-A study) is planned to conduct in 80 centres from China and recruit a total of 12 000 adult participants undergoing a surgical procedure under general anaesthesia. Patient recruitment started in June 2021 and will end in June 2022. Participants will be randomised in a ratio of 2:1 to either receive perioperative intravenous S(+)-ketamine plus conventional anaesthesia or conventional anaesthesia only. Given the pragmatic nature of the study, no specific restriction as to the administration dosage, route, time, synergistic regimen or basic analgesics. Primary endpoints are the area under the broken line of Numerical Rating Scale (NRS) scores for pain intensity and the total opioid consumption within 48 hours postoperative. Secondary endpoints are postoperative NRS scores, the anaesthesia recovery time, time of first rescue analgesia, the incidence of rescue analgesia, the incidence of postoperative delirium, patient questionnaire for effect, changes from baseline in cognitive function and anxiety and depression, as well as the adverse events and pharmacoeconomic outcomes. The general linear model will be used for the primary endpoint, and appropriate methods will be used for the secondary endpoints.
    Ethics and dissemination: This trial has been approved by the local Institutional Review Board (S2021-026-02) and conducted following the Declaration of Helsinki. Results of this trial will be publicly disclosed and published in scientific journals.
    Trial registration number: NCT04837170; Pre-results.
    MeSH term(s) Adult ; Analgesics/therapeutic use ; Analgesics, Opioid/therapeutic use ; Humans ; Ketamine/therapeutic use ; Multicenter Studies as Topic ; Pain Measurement ; Pain, Postoperative/drug therapy ; Pain, Postoperative/etiology ; Randomized Controlled Trials as Topic
    Chemical Substances Analgesics ; Analgesics, Opioid ; Ketamine (690G0D6V8H)
    Language English
    Publishing date 2021-12-16
    Publishing country England
    Document type Clinical Trial Protocol ; Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2599832-8
    ISSN 2044-6055 ; 2044-6055
    ISSN (online) 2044-6055
    ISSN 2044-6055
    DOI 10.1136/bmjopen-2021-054681
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Penehyclidine hydrochloride preserves the intestinal barrier function in patients undergoing cardiopulmonary bypass.

    Sun, Ying-jie / Song, Dan-dan / Diao, Yu-gang / Zhou, Jin / Zhang, Tie-zheng

    The Journal of thoracic and cardiovascular surgery

    2013  Volume 146, Issue 1, Page(s) 179–185

    Abstract: Objective: The study objective was to investigate the protective effect of penehyclidine hydrochloride on intestinal barrier function integrity and its therapeutic potential on endotoxemia and systemic inflammatory response in patients undergoing ... ...

    Abstract Objective: The study objective was to investigate the protective effect of penehyclidine hydrochloride on intestinal barrier function integrity and its therapeutic potential on endotoxemia and systemic inflammatory response in patients undergoing cardiopulmonary bypass.
    Methods: Forty patients undergoing cardiac valve replacement with cardiopulmonary bypass were enrolled in the study. All patients were randomly divided into the penehyclidine hydrochloride or control group (20 patients in each group). Patients in the penehyclidine hydrochloride group received an intravenous injection of 0.05 mg/kg penehyclidine hydrochloride 10 minutes before cardiopulmonary bypass, and those in the control group were given the same volume of saline. Blood samples for blood glucose, lactic acid, intestinal fatty acid binding protein, D-lactate, serum endotoxin (lipopolysaccharide), interleukin-6, and interleukin-10 measurements were collected during the following time points: immediately after anesthesia induction (T0), 10 minutes after the release of aortic-clamping (T1), immediately after weaning from cardiopulmonary bypass (T2), 2 hours postoperatively (T3), 6 hours postoperatively (T4), and 18 hours postoperatively (T5).
    Results: Blood glucose, lactic acid, intestinal fatty acid binding protein, D-lactate, lipopolysaccharide, interleukin-6, and interleukin-10 were significantly increased at all postoperative time points. At specific postoperative time points, blood glucose, lactic acid, intestinal fatty acid binding protein, D-lactate, lipopolysaccharide, and interleukin-6 were statistically lower in the penehyclidine hydrochloride group than in the control group. Postoperatively, interleukin-10 did not differ between the penehyclidine hydrochloride and control groups.
    Conclusions: Penehyclidine hydrochloride preserves intestinal barrier function integrity, attenuates endotoxemia, and inhibits systemic inflammatory response in patients undergoing cardiopulmonary bypass, possibly by improving intestinal microcirculation and depressing stress response.
    MeSH term(s) Cardiopulmonary Bypass ; Endotoxemia/prevention & control ; Female ; Humans ; Intestinal Mucosa/drug effects ; Intestinal Mucosa/physiology ; Male ; Middle Aged ; Prospective Studies ; Quinuclidines/therapeutic use ; Systemic Inflammatory Response Syndrome/prevention & control
    Chemical Substances Quinuclidines ; penehyclidine (353CX8CSHD)
    Language English
    Publishing date 2013-02-21
    Publishing country United States
    Document type Journal Article ; Randomized Controlled Trial ; Research Support, Non-U.S. Gov't
    ZDB-ID 3104-5
    ISSN 1097-685X ; 0022-5223
    ISSN (online) 1097-685X
    ISSN 0022-5223
    DOI 10.1016/j.jtcvs.2013.01.042
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Penehyclidine hydrochloride attenuates the cerebral injury in a rat model of cardiopulmonary bypass.

    Cao, Hui-juan / Sun, Ying-jie / Zhang, Tie-zheng / Zhou, Jin / Diao, Yu-gang

    Canadian journal of physiology and pharmacology

    2013  Volume 91, Issue 7, Page(s) 521–527

    Abstract: This study investigated the effect of penehyclidine hydrochloride (PHC) on regulatory mediators during the neuroinflammatory response and cerebral cell apoptosis following cardiopulmonary bypass (CPB). Forty-eight rats were randomly divided among 4 ... ...

    Abstract This study investigated the effect of penehyclidine hydrochloride (PHC) on regulatory mediators during the neuroinflammatory response and cerebral cell apoptosis following cardiopulmonary bypass (CPB). Forty-eight rats were randomly divided among 4 groups as follows: sham-operation, vehicle, low-dose PHC (0.6 mg·(kg body mass)(-1)), and high-dose PHC (2.0 mg·(kg body mass)(-1)). CPB was performed in the latter 3 groups. The plasma levels of neuron specific enolase (NSE) and S-100B were tested with ELISA. Real-time PCR and Western blotting were used to evaluate the expression levels of matrix metalloproteinase-9 (MMP-9), IL-10, caspase-3, Bcl-2, and p38 in brain tissue. The ultrastructure of hippocampus tissue was examined under an electron microscope. PHC attenuated the increase of plasma NSE and S-100B following CPB. MMP-9, cleaved caspase-3, and phosphorylated p38 expression were substantially increased in the vehicle group compared with the sham-operation group and gradually diminished with increasing doses of PHC. IL-10 and Bcl-2 expression were markedly lower in the vehicle group than in the sham-operation group and gradually recovered with increasing doses of PHC. PHC attenuated the histopathological changes of cerebral injury following CPB. PHC favorably regulates the inflammatory response and reduces markers of neuronal injury following CPB, potentially by reducing p38 and caspase-3 activation.
    MeSH term(s) Animals ; Apoptosis/drug effects ; Brain Injuries/drug therapy ; Brain Injuries/etiology ; Brain Injuries/genetics ; Brain Injuries/metabolism ; Cardiopulmonary Bypass/adverse effects ; Cardiopulmonary Bypass/methods ; Caspase 3/biosynthesis ; Caspase 3/genetics ; Caspase 3/metabolism ; Cerebrum/drug effects ; Cerebrum/metabolism ; Cerebrum/pathology ; Female ; Hemodynamics/drug effects ; Hippocampus/drug effects ; Hippocampus/metabolism ; Hippocampus/pathology ; Inflammation/drug therapy ; Inflammation/genetics ; Inflammation/metabolism ; Interleukin-10/biosynthesis ; Interleukin-10/genetics ; Interleukin-10/metabolism ; Male ; Matrix Metalloproteinase 9/biosynthesis ; Matrix Metalloproteinase 9/genetics ; Matrix Metalloproteinase 9/metabolism ; Phosphopyruvate Hydratase/blood ; Phosphopyruvate Hydratase/metabolism ; Phosphorylation/drug effects ; Phosphorylation/genetics ; Proto-Oncogene Proteins c-bcl-2/biosynthesis ; Proto-Oncogene Proteins c-bcl-2/genetics ; Proto-Oncogene Proteins c-bcl-2/metabolism ; Quinuclidines/pharmacology ; RNA, Messenger/biosynthesis ; RNA, Messenger/genetics ; Rats ; Rats, Sprague-Dawley ; S100 Calcium Binding Protein beta Subunit/blood ; S100 Calcium Binding Protein beta Subunit/metabolism ; p38 Mitogen-Activated Protein Kinases/genetics ; p38 Mitogen-Activated Protein Kinases/metabolism
    Chemical Substances Proto-Oncogene Proteins c-bcl-2 ; Quinuclidines ; RNA, Messenger ; S100 Calcium Binding Protein beta Subunit ; Interleukin-10 (130068-27-8) ; penehyclidine (353CX8CSHD) ; p38 Mitogen-Activated Protein Kinases (EC 2.7.11.24) ; Caspase 3 (EC 3.4.22.-) ; Matrix Metalloproteinase 9 (EC 3.4.24.35) ; Phosphopyruvate Hydratase (EC 4.2.1.11)
    Language English
    Publishing date 2013-03-12
    Publishing country Canada
    Document type Journal Article
    ZDB-ID 127527-6
    ISSN 1205-7541 ; 0008-4212
    ISSN (online) 1205-7541
    ISSN 0008-4212
    DOI 10.1139/cjpp-2012-0329
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Probiotics can alleviate cardiopulmonary bypass-induced intestinal mucosa damage in rats.

    Sun, Ying-Jie / Cao, Hui-Juan / Song, Dan-Dan / Diao, Yu-Gang / Zhou, Jin / Zhang, Tie-Zheng

    Digestive diseases and sciences

    2013  Volume 58, Issue 6, Page(s) 1528–1536

    Abstract: Background: Cardiopulmonary bypass (CPB) is commonly applied to support circulation during heart surgery but frequently causes adverse effects.: Aims: The purpose of this study was to examine the potential of probiotics to improve small intestinal ... ...

    Abstract Background: Cardiopulmonary bypass (CPB) is commonly applied to support circulation during heart surgery but frequently causes adverse effects.
    Aims: The purpose of this study was to examine the potential of probiotics to improve small intestinal mucosa barrier function after CPB.
    Methods: Twenty-four adult male SD rats were randomly divided into sham-operated (S), CPB-operated (CPB), and probiotic-fed (Y) groups. Diamine oxidase (DAO) activity and concentrations of D-lactic acid, endotoxin, TNFα, and IL-6 were measured in portal vein blood. IgA concentrations were determined in plasma and the small intestine. Vena cava blood and tissue samples were used to monitor bacterial growth. Intestinal epithelial ultrastructure was analyzed by transmission electron microscopy (TEM). Occludin and ZO-1 expression levels in the intestinal epithelium were detected by western blotting and immunohistochemistry, respectively.
    Results: D-lactic acid, endotoxin, TNFα and IL-6 levels, DAO activity, and bacterial translocation rate were increased (P < 0.05) in CPB and Y compared to the S group. The above indices were relatively lower (P < 0.05) in Y than in CPB. Plasma and small intestinal IgA levels were significantly lower (P < 0.05) in CPB, while in Y they were significantly increased (P < 0.05) but lower than in S (P < 0.05). These results were confirmed by TEM. Consistently, occludin and ZO-1 expression levels were significantly higher in Y than in CPB (P < 0.05) but still lower compared to S (P < 0.05).
    Conclusion: Pre-administration of probiotics can improve, to some extent, intestinal barrier function after CPB in rats, and this effect is likely related to inhibition of the CPB-induced inflammatory response, improvement in local intestinal immune function, and increased expression of intestinal epithelial tight junction proteins.
    MeSH term(s) Animals ; Bacterial Translocation ; Biomarkers/metabolism ; Blotting, Western ; Cardiopulmonary Bypass/adverse effects ; Immunoglobulin A/metabolism ; Immunohistochemistry ; Intestinal Mucosa/metabolism ; Intestinal Mucosa/microbiology ; Intestinal Mucosa/physiopathology ; Intestinal Mucosa/ultrastructure ; Intestine, Small/metabolism ; Intestine, Small/microbiology ; Intestine, Small/physiopathology ; Intestine, Small/ultrastructure ; Male ; Microscopy, Electron, Transmission ; Preoperative Care ; Probiotics/administration & dosage ; Probiotics/pharmacology ; Random Allocation ; Rats ; Rats, Sprague-Dawley ; Tight Junctions/metabolism
    Chemical Substances Biomarkers ; Immunoglobulin A
    Language English
    Publishing date 2013-01-19
    Publishing country United States
    Document type Evaluation Study ; Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 304250-9
    ISSN 1573-2568 ; 0163-2116
    ISSN (online) 1573-2568
    ISSN 0163-2116
    DOI 10.1007/s10620-012-2546-0
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Effects of penehyclidine hydrochloride on rat intestinal barrier function during cardiopulmonary bypass.

    Sun, Ying-Jie / Cao, Hui-Juan / Jin, Qiang / Diao, Yu-Gang / Zhang, Tie-Zheng

    World journal of gastroenterology

    2008  Volume 17, Issue 16, Page(s) 2137–2142

    Abstract: Aim: To test the ability of penehyclidine hydrochloride (PHC) to attenuate intestinal injury in a rat cardiopulmonary bypass (CPB) model.: Methods: Male Sprague-Dawley rats were randomly divided into six groups (eight each): sham-operated control; ... ...

    Abstract Aim: To test the ability of penehyclidine hydrochloride (PHC) to attenuate intestinal injury in a rat cardiopulmonary bypass (CPB) model.
    Methods: Male Sprague-Dawley rats were randomly divided into six groups (eight each): sham-operated control; sham-operated low-dose PHC control (0.6 mg/kg); sham-operated high-dose PHC control (2.0 mg/kg); CPB vehicle control; CPB low-dose PHC (0.6 mg/kg); and CPB high-dose PHC (2.0 mg/kg). Blood samples were collected from the femoral artery 2 h after CPB for determination of plasma diamine oxidase (DAO), D-lactate and endotoxin levels. Spleen, liver, mesenteric lymph nodes and lung were removed for biochemical analyses. Intestinal tissue ultrastructure was examined by electron microscopy.
    Results: In the sham-operated groups, high- and low-dose-PHC had no significant impact on the levels of DAO, D-lactate and endotoxin, or the incidence of intestinal bacterial translocation (BT). Serum levels of DAO, D-lactate, endotoxin and the incidence of intestinal BT were significantly increased in the surgical groups, compared with the sham-operated groups (0.543 ± 0.061, 5.697 ± 0.272, 14.75 ± 2.46, and 0/40 vs 1.038 ± 0.252, 9.377 ± 0.769, 60.37 ± 5.63, and 30/40, respectively, all P < 0.05). PHC alleviated the biochemical and histopathological changes in a dose-dependent manner. Serum levels of DAO, D-lactate, and endotoxin and the incidence of intestinal BT in the high-dose PHC group were significantly lower than in the low-dose PHC group (0.637 ± 0.064, 6.972 ± 0.349, 29.64 ± 5.49, and 14/40 vs 0.998 ± 0.062, 7.835 ± 0.330, 38.56 ± 4.28, and 6/40, respectively, all P < 0.05).
    Conclusion: PHC protects the structure and function of the intestinal mucosa from injury after CPB in rats.
    MeSH term(s) Animals ; Cardiopulmonary Bypass/adverse effects ; Humans ; Intestinal Mucosa/drug effects ; Intestinal Mucosa/injuries ; Intestinal Mucosa/physiology ; Intestinal Mucosa/ultrastructure ; Male ; Quinuclidines/pharmacology ; Random Allocation ; Rats ; Rats, Sprague-Dawley
    Chemical Substances Quinuclidines ; penehyclidine (353CX8CSHD)
    Language English
    Publishing date 2008-05-08
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2185929-2
    ISSN 2219-2840 ; 1007-9327
    ISSN (online) 2219-2840
    ISSN 1007-9327
    DOI 10.3748/wjg.v17.i16.2137
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article: [Effects of peripheral benzodiazepine receptor on cardiomyocytes apoptosis induced by hypoxia and reoxygenation in rats].

    Diao, Yu-gang / Zu, Jian-yu / Liu, Hai-mei / Liu, Jie / Ma, Hong / Wang, Jun-ke

    Zhongguo wei zhong bing ji jiu yi xue = Chinese critical care medicine = Zhongguo weizhongbing jijiuyixue

    2007  Volume 19, Issue 11, Page(s) 691–692

    MeSH term(s) Animals ; Apoptosis ; Cell Hypoxia/physiology ; Cells, Cultured ; Female ; Male ; Myocytes, Cardiac/pathology ; Rats ; Rats, Wistar ; Receptors, GABA-A/physiology
    Chemical Substances Receptors, GABA-A
    Language Chinese
    Publishing date 2007-11
    Publishing country China
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ISSN 1003-0603
    ISSN 1003-0603
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top